These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33273326)

  • 1. Clinical features and treatment outcomes of human immunodeficiency virus-associated cryptococcal meningitis: a 2-year retrospective analysis.
    Song W; Shen YZ; Wang ZY; Qi TK; Liu L; Zhang RF; Wang JR; Tang Y; Chen J; Sun JJ; Lu HZ
    Chin Med J (Engl); 2020 Dec; 133(23):2787-2795. PubMed ID: 33273326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons of clinical features and mortality of cryptococcal meningitis between patients with and without human immunodeficiency virus infection.
    Lee YC; Wang JT; Sun HY; Chen YC
    J Microbiol Immunol Infect; 2011 Oct; 44(5):338-45. PubMed ID: 21524972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes.
    Jarvis JN; Bicanic T; Loyse A; Namarika D; Jackson A; Nussbaum JC; Longley N; Muzoora C; Phulusa J; Taseera K; Kanyembe C; Wilson D; Hosseinipour MC; Brouwer AE; Limmathurotsakul D; White N; van der Horst C; Wood R; Meintjes G; Bradley J; Jaffar S; Harrison T
    Clin Infect Dis; 2014 Mar; 58(5):736-45. PubMed ID: 24319084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics, treatment, and outcome of low-risk non-HIV-associated cryptococcal meningitis: A retrospective cohort study.
    Liu J; Dong R; Zhang H; Yao S; Liu J; Yang L; Fan L; Su X; Wang A; Su Z; Ngai IK; Dai K; Jiang Y; Peng F
    Med Mycol; 2023 Dec; 61(12):. PubMed ID: 38031335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
    Sloan D; Dlamini S; Paul N; Dedicoat M
    Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different presentations and outcomes between HIV-infected and HIV-uninfected patients with Cryptococcal meningitis.
    Liao CH; Chi CY; Wang YJ; Tseng SW; Chou CH; Ho CM; Lin PC; Ho MW; Wang JH
    J Microbiol Immunol Infect; 2012 Aug; 45(4):296-304. PubMed ID: 22608531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of cerebrospinal fluid white cell count during the prognostic assessment for cryptococcal meningitis patients: a retrospective study.
    Qu J; Jiang J; Lv X
    BMC Infect Dis; 2020 Aug; 20(1):571. PubMed ID: 32758162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of quantitative CSF microscopy to predict culture status and outcome in HIV-associated cryptococcal meningitis in a Brazilian cohort.
    Vidal JE; Gerhardt J; Peixoto de Miranda EJ; Dauar RF; Oliveira Filho GS; Penalva de Oliveira AC; Boulware DR
    Diagn Microbiol Infect Dis; 2012 May; 73(1):68-73. PubMed ID: 22578940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of Epstein-Barr virus in cerebrospinal fluid is associated with increased mortality in HIV-negative cryptococcal meningitis.
    Lu Y; Li S; Su Z; Luo C; Gu M; Yuan D; Qin BE; Dai K; Xia H; Chen Y; Peng F; Jiang Y
    Med Mycol; 2024 May; 62(5):. PubMed ID: 38710585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased cryptococcal meningitis mortality among HIV negative, non-transplant patients: a single US center cohort study.
    Motoa G; Pate A; Chastain D; Mann S; Canfield GS; Franco-Paredes C; Henao-Martínez AF
    Ther Adv Infect Dis; 2020; 7():2049936120940881. PubMed ID: 32685148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptococcal meningitis in Lilongwe and Blantyre, Malawi.
    Maher D; Mwandumba H
    J Infect; 1994 Jan; 28(1):59-64. PubMed ID: 8163834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa.
    Makadzange AT; Ndhlovu CE; Takarinda K; Reid M; Kurangwa M; Gona P; Hakim JG
    Clin Infect Dis; 2010 Jun; 50(11):1532-8. PubMed ID: 20415574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension in patients with HIV-associated cryptococcal meningitis with or without hydrocephalus.
    Liu L; Zhang R; Tang Y; Lu H
    Biosci Trends; 2014 Dec; 8(6):327-32. PubMed ID: 25641179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis.
    Bisson GP; Molefi M; Bellamy S; Thakur R; Steenhoff A; Tamuhla N; Rantleru T; Tsimako I; Gluckman S; Ravimohan S; Weissman D; Tebas P
    Clin Infect Dis; 2013 Apr; 56(8):1165-73. PubMed ID: 23362285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-17 mediated differences in the pathogenesis of HIV-1-associated tuberculous and cryptococcal meningitis.
    Marais S; Meintjes G; Lesosky M; Wilkinson KA; Wilkinson RJ
    AIDS; 2016 Jan; 30(3):395-404. PubMed ID: 26765934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal Fluid Shunting in Children with Hydrocephalus and Increased Intracranial Pressure Secondary to Human Immunodeficiency Virus-Related Cryptococcal Meningitis.
    Enicker B; Aldous C
    World Neurosurg; 2022 Dec; 168():e530-e537. PubMed ID: 36228933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a machine learning model to predict prognosis in HIV-negative cryptococcal meningitis patients: a multicenter study.
    Liu J; Lu Y; Liu J; Liang J; Zhang Q; Li H; Zhong X; Bu H; Wang Z; Fan L; Liang P; Xie J; Wang Y; Gong J; Chen H; Dai Y; Yang L; Su X; Wang A; Xiong L; Xia H; Jiang Y; Liu Z; Peng F
    Eur J Clin Microbiol Infect Dis; 2023 Oct; 42(10):1183-1194. PubMed ID: 37606868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CLINICAL OUTCOMES OF CRYPTOCOCCAL MENINGITIS AMONG HIV-INFECTED PATIENTS IN THE ERA OF ANTIRETROVIRAL THERAPY.
    Kobayashi T; Pitisuttithum P; Kaewkingwal J; Phuphuakrat A; Sungkanuparph S
    Southeast Asian J Trop Med Public Health; 2017 Jan; 48(1):56-64. PubMed ID: 29644820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis.
    Eshun-Wilson I; Okwen MP; Richardson M; Bicanic T
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009012. PubMed ID: 30039850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptococcal Meningitis and Clinical Outcomes in Persons With Human Immunodeficiency Virus: A Global View.
    Person AK; Crabtree-Ramirez B; Kim A; Veloso V; Maruri F; Wandeler G; Fox M; Moore R; John Gill M; Imran D; Van Nguyen K; Nalitya E; Muyindike W; Shepherd BE; McGowan CC
    Clin Infect Dis; 2023 Jun; 76(12):2116-2125. PubMed ID: 36821489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.